Stay updated on Pemigatinib Dose-Escalation Clinical Trial
Sign up to get notified when there's something new on the Pemigatinib Dose-Escalation Clinical Trial page.

Latest updates to the Pemigatinib Dose-Escalation Clinical Trial page
- CheckyesterdayChange DetectedThe footer’s site revision identifier changed from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study details, blocking access to the study record and related documents. This change changes the page’s usability by preventing access to its primary content.SummaryDifference25%

- Check22 days agoChange DetectedRevision tag updated from v3.6.6 to v3.7.0. This represents a backend/template update and does not alter the study details shown on the page.SummaryDifference0.0%

- Check36 days agoChange DetectedRevision label updated from v3.6.5 to v3.6.6 on the page, indicating a newer build of the site; no substantive changes to the study details are reflected.SummaryDifference0.0%

- Check57 days agoChange DetectedPage revision tag updated from v3.6.4 to v3.6.5. This reflects a new page version without changing the substantive study content.SummaryDifference0.0%

- Check78 days agoChange DetectedRevision label updated from v3.6.3 to v3.6.4, indicating a minor version update to the page/system.SummaryDifference0.0%

Stay in the know with updates to Pemigatinib Dose-Escalation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pemigatinib Dose-Escalation Clinical Trial page.